The Competition and Markets Authority (CMA) has today issued a statement clarifying that certain types of engagements between competing drug firms working on ‘combination therapies’ will not be prioritized for investigation – making it easier for drug firms to work together to develop vital treatments for use in the NHS.
Empowering individuals with knowledge, fostering healthier lifestyles, and fostering a community dedicated to diabetes awareness and prevention. Together, we’re shaping a healthier future.
Subscribe To Us
By submitting via this part of the website you are granting us permission to store and process your data according to our Standard privacy policy
© 2024 Diabetes Prevention Awareness Center.